Cargando…
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568092/ https://www.ncbi.nlm.nih.gov/pubmed/34735426 http://dx.doi.org/10.15585/mmwr.mm7044e3 |
| _version_ | 1784594359986946048 |
|---|---|
| author | Embi, Peter J. Levy, Matthew E. Naleway, Allison L. Patel, Palak Gaglani, Manjusha Natarajan, Karthik Dascomb, Kristin Ong, Toan C. Klein, Nicola P. Liao, I-Chia Grannis, Shaun J. Han, Jungmi Stenehjem, Edward Dunne, Margaret M. Lewis, Ned Irving, Stephanie A. Rao, Suchitra McEvoy, Charlene Bozio, Catherine H. Murthy, Kempapura Dixon, Brian E. Grisel, Nancy Yang, Duck-Hye Goddard, Kristin Kharbanda, Anupam B. Reynolds, Sue Raiyani, Chandni Fadel, William F. Arndorfer, Julie Rowley, Elizabeth A. Fireman, Bruce Ferdinands, Jill Valvi, Nimish R. Ball, Sarah W. Zerbo, Ousseny Griggs, Eric P. Mitchell, Patrick K. Porter, Rachael M. Kiduko, Salome A. Blanton, Lenee Zhuang, Yan Steffens, Andrea Reese, Sarah E. Olson, Natalie Williams, Jeremiah Dickerson, Monica McMorrow, Meredith Schrag, Stephanie J. Verani, Jennifer R. Fry, Alicia M. Azziz-Baumgartner, Eduardo Barron, Michelle A. Thompson, Mark G. DeSilva, Malini B. |
| author_facet | Embi, Peter J. Levy, Matthew E. Naleway, Allison L. Patel, Palak Gaglani, Manjusha Natarajan, Karthik Dascomb, Kristin Ong, Toan C. Klein, Nicola P. Liao, I-Chia Grannis, Shaun J. Han, Jungmi Stenehjem, Edward Dunne, Margaret M. Lewis, Ned Irving, Stephanie A. Rao, Suchitra McEvoy, Charlene Bozio, Catherine H. Murthy, Kempapura Dixon, Brian E. Grisel, Nancy Yang, Duck-Hye Goddard, Kristin Kharbanda, Anupam B. Reynolds, Sue Raiyani, Chandni Fadel, William F. Arndorfer, Julie Rowley, Elizabeth A. Fireman, Bruce Ferdinands, Jill Valvi, Nimish R. Ball, Sarah W. Zerbo, Ousseny Griggs, Eric P. Mitchell, Patrick K. Porter, Rachael M. Kiduko, Salome A. Blanton, Lenee Zhuang, Yan Steffens, Andrea Reese, Sarah E. Olson, Natalie Williams, Jeremiah Dickerson, Monica McMorrow, Meredith Schrag, Stephanie J. Verani, Jennifer R. Fry, Alicia M. Azziz-Baumgartner, Eduardo Barron, Michelle A. Thompson, Mark G. DeSilva, Malini B. |
| author_sort | Embi, Peter J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8568092 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85680922021-11-18 Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 Embi, Peter J. Levy, Matthew E. Naleway, Allison L. Patel, Palak Gaglani, Manjusha Natarajan, Karthik Dascomb, Kristin Ong, Toan C. Klein, Nicola P. Liao, I-Chia Grannis, Shaun J. Han, Jungmi Stenehjem, Edward Dunne, Margaret M. Lewis, Ned Irving, Stephanie A. Rao, Suchitra McEvoy, Charlene Bozio, Catherine H. Murthy, Kempapura Dixon, Brian E. Grisel, Nancy Yang, Duck-Hye Goddard, Kristin Kharbanda, Anupam B. Reynolds, Sue Raiyani, Chandni Fadel, William F. Arndorfer, Julie Rowley, Elizabeth A. Fireman, Bruce Ferdinands, Jill Valvi, Nimish R. Ball, Sarah W. Zerbo, Ousseny Griggs, Eric P. Mitchell, Patrick K. Porter, Rachael M. Kiduko, Salome A. Blanton, Lenee Zhuang, Yan Steffens, Andrea Reese, Sarah E. Olson, Natalie Williams, Jeremiah Dickerson, Monica McMorrow, Meredith Schrag, Stephanie J. Verani, Jennifer R. Fry, Alicia M. Azziz-Baumgartner, Eduardo Barron, Michelle A. Thompson, Mark G. DeSilva, Malini B. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2021-11-05 /pmc/articles/PMC8568092/ /pubmed/34735426 http://dx.doi.org/10.15585/mmwr.mm7044e3 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Embi, Peter J. Levy, Matthew E. Naleway, Allison L. Patel, Palak Gaglani, Manjusha Natarajan, Karthik Dascomb, Kristin Ong, Toan C. Klein, Nicola P. Liao, I-Chia Grannis, Shaun J. Han, Jungmi Stenehjem, Edward Dunne, Margaret M. Lewis, Ned Irving, Stephanie A. Rao, Suchitra McEvoy, Charlene Bozio, Catherine H. Murthy, Kempapura Dixon, Brian E. Grisel, Nancy Yang, Duck-Hye Goddard, Kristin Kharbanda, Anupam B. Reynolds, Sue Raiyani, Chandni Fadel, William F. Arndorfer, Julie Rowley, Elizabeth A. Fireman, Bruce Ferdinands, Jill Valvi, Nimish R. Ball, Sarah W. Zerbo, Ousseny Griggs, Eric P. Mitchell, Patrick K. Porter, Rachael M. Kiduko, Salome A. Blanton, Lenee Zhuang, Yan Steffens, Andrea Reese, Sarah E. Olson, Natalie Williams, Jeremiah Dickerson, Monica McMorrow, Meredith Schrag, Stephanie J. Verani, Jennifer R. Fry, Alicia M. Azziz-Baumgartner, Eduardo Barron, Michelle A. Thompson, Mark G. DeSilva, Malini B. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 |
| title | Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 |
| title_full | Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 |
| title_fullStr | Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 |
| title_full_unstemmed | Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 |
| title_short | Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 |
| title_sort | effectiveness of 2-dose vaccination with mrna covid-19 vaccines against covid-19–associated hospitalizations among immunocompromised adults — nine states, january–september 2021 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568092/ https://www.ncbi.nlm.nih.gov/pubmed/34735426 http://dx.doi.org/10.15585/mmwr.mm7044e3 |
| work_keys_str_mv | AT embipeterj effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT levymatthewe effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT nalewayallisonl effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT patelpalak effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT gaglanimanjusha effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT natarajankarthik effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT dascombkristin effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT ongtoanc effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT kleinnicolap effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT liaoichia effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT grannisshaunj effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT hanjungmi effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT stenehjemedward effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT dunnemargaretm effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT lewisned effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT irvingstephaniea effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT raosuchitra effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT mcevoycharlene effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT boziocatherineh effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT murthykempapura effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT dixonbriane effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT griselnancy effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT yangduckhye effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT goddardkristin effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT kharbandaanupamb effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT reynoldssue effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT raiyanichandni effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT fadelwilliamf effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT arndorferjulie effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT rowleyelizabetha effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT firemanbruce effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT ferdinandsjill effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT valvinimishr effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT ballsarahw effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT zerboousseny effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT griggsericp effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT mitchellpatrickk effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT porterrachaelm effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT kidukosalomea effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT blantonlenee effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT zhuangyan effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT steffensandrea effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT reesesarahe effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT olsonnatalie effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT williamsjeremiah effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT dickersonmonica effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT mcmorrowmeredith effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT schragstephaniej effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT veranijenniferr effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT fryaliciam effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT azzizbaumgartnereduardo effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT barronmichellea effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT thompsonmarkg effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 AT desilvamalinib effectivenessof2dosevaccinationwithmrnacovid19vaccinesagainstcovid19associatedhospitalizationsamongimmunocompromisedadultsninestatesjanuaryseptember2021 |